发明名称 CRYSTALLINE ß2 ADRENERGIC RECEPTOR AGONIST
摘要 THE INVENTION PROVIDES A CRYSTALLINE SALT FORM OF A NOVEL 2 ADRENERGIC RECEPTOR AGONIST. THE INVENTION ALSO PROVIDES PHARMACEUTICAL COMPOSITIONS COMPRISING THE CRYSTALLINE FORM, FORMULATIONS CONTAINING THE PHARMACEUTICAL COMPOSITIONS, METHODS OF USING THE CRYSTALLINE SALT FORM TO TREAT DISEASES ASSOCIATED WITH 2 ADRENERGIC RECEPTOR ACTIVITY, AND PROCESSES USEFUL FOR PREPARING SUCH A CRYSTALLINE COMPOUND.
申请公布号 MY139296(A) 申请公布日期 2009.09.30
申请号 MYPI20032804 申请日期 2003.07.25
申请人 THERAVANCE, INC. 发明人 MARTIN S. LINSELL;JOHN R. JACOBSEN;DAVAR KHOSSRAVI;MEHDI PABORJI;WEIJIANG ZHANG
分类号 A61K9/12;A61K9/72;A61K31/167;A61K31/56;A61K31/573;A61P9/00;A61P11/00;A61P11/04;A61P15/06;A61P25/00;A61P29/00;C07C213/04;C07C213/10;C07C215/30;C07C233/43 主分类号 A61K9/12
代理机构 代理人
主权项
地址